Teneligliptin Hydrobromide Intermediate CAS 401564-36-1 Mimọ> 99.5% (HPLC) Ile-iṣẹ
Ipese Teneligliptin Hydrobromide Ni ibatan Intermediates Pẹlu Giga Mimo
Teneligliptin Hydrobromide CAS 906093-29-6
1- (3-Methyl-1-Phenyl-5-Pyrazoyl) piperazine CAS 401566-79-8
Teneligliptin Hydrobromide Intermediate CAS 401564-36-1
| Orukọ Kemikali | (2S)-4-Oxo-2- (3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
| Awọn itumọ ọrọ sisọ | (S) -tert-Butyl 4-oxo-2- (thiazolidine-3-carbonyl) pyrrolidine-1-carboxylate;3-((S) -1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl) -1,3-thiazolidine;(2S) -4-oxo-2- (1,3-thiazolidin-3-ylcarbonyl) pyrrolidine-1-carboxylate;Teneliptin Intermediate B |
| Nọmba CAS | 401564-36-1 |
| NỌMBA CAT | RF-1818 |
| Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu |
| Ilana molikula | C13H20N2O4S |
| Òṣuwọn Molikula | 300.37 |
| iwuwo | 1.305 |
| Brand | Ruifu Kemikali |
| Nkan | Standard ayewo | Esi |
| Ifarahan | Funfun to Ipara Awọ Ri to | Ṣe ibamu |
| Idanimọ | IR;HPLC RT | Ṣe ibamu |
| Pipadanu lori Gbigbe | <1.00% | 0.20% |
| Awọn nkan ti o jọmọ | Eyikeyi aimọ Kankan <0.50% | 0.24% |
| Àpapọ̀ àìmọ́ <0.50% | 0.39% | |
| Ayẹwo | 99.5% ~ 102.0% (Lori ipilẹ gbigbe) | 99.8% |
| Enantiomeric ti nw | > 99.5% | 99.9% |
| Sulfated Ash | <0.20% | 0.02% |
| Igbeyewo Standard | Standard Enterprise | |
| Lilo | Awọn agbedemeji ti Teneligliptin Hydrobromide (CAS: 906093-29-6) | |
Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin
(2S) -4-Oxo-2- (3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) jẹ agbedemeji ti a lo lati mura dipeptidyl peptidase IV (DPP-IV) inhibitor, awọn agbedemeji. ti Teneligliptin Hydrobromide (CAS: 906093-29-6).Teneligliptin jẹ inhibitor DPP-4 eyiti a fọwọsi ni Japan ni ọdun 2012 fun itọju iru àtọgbẹ II.O jẹ awari ati idagbasoke nipasẹ Mitsubishi Tanabe Pharma labẹ orukọ iṣowo Tenelia®.Gẹgẹbi awọn inhibitors DPP-4 miiran ti ọja, Teneligliptin ni ifarada daradara ni gbogbo awọn iwadii ati iwọn lilo QD ṣe agbejade igbese inhibitory pipẹ ni ilodi si DPP-4 ati ilosoke ninu awọn ipele GLP-1 ti nṣiṣe lọwọ, pẹlu awọn iwọn kekere pupọ ti iyọkuro kidirin.
